Announcements

We are pleased to invite you to read the most viewed papers in 2023 in Cancers (ISSN: 2072-6694) in the Section “Molecular Cancer Biology”. The paper list is as follows:

“Downregulation of Dystrophin Expression Occurs across Diverse Tumors, Correlates with the Age of Onset, Staging and Reduced Survival of Patients”
by Nancy Alnassar, Malgorzata Borczyk, Georgia Tsagkogeorga, Michal Korostynski, Namshik Han and Dariusz C. Górecki
Cancers 2023, 15(5), 1378; https://doi.org/10.3390/cancers15051378
Available online: https://www.mdpi.com/2072-6694/15/5/1378

“The Role of Different Immunocompetent Cell Populations in the Pathogenesis of Head and Neck Cancer—Regulatory Mechanisms of Pro- and Anti-Cancer Activity and Their Impact on Immunotherapy”
by Katarzyna Starska-Kowarska
Cancers 2023, 15(6), 1642; https://doi.org/10.3390/cancers15061642
Available online: https://www.mdpi.com/2072-6694/15/6/1642

“Resistance to Antibody-Drug Conjugates Targeting HER2 in Breast Cancer: Molecular Landscape and Future Challenges”
by Lorenzo Guidi, Gloria Pellizzari, Paolo Tarantino, Carmine Valenza and Giuseppe Curigliano
Cancers 2023, 15(4), 1130; https://doi.org/10.3390/cancers15041130
Available online: https://www.mdpi.com/2072-6694/15/4/1130

“Principles of Molecular Utility for CMS Classification in Colorectal Cancer Management”
by Leili Rejali, Romina Seifollahi Asl, Fatemeh Sanjabi, Nayeralsadat Fatemi, Hamid Asadzadeh Aghdaei, Mahsa Saeedi Niasar, Pardis Ketabi Moghadam, Ehsan Nazemalhosseini Mojarad, Enrico Mini and Stefania Nobili
Cancers 2023, 15(10), 2746; https://doi.org/10.3390/cancers15102746
Available online: https://www.mdpi.com/2072-6694/15/10/2746

“The BAFF-APRIL System in Cancer”
by Md Ashik Ullah and Fabienne Mackay
Cancers 2023, 15(6), 1791; https://doi.org/10.3390/cancers15061791
Available online: https://www.mdpi.com/2072-6694/15/6/1791

“Downstream Targets of VHL/HIF-α Signaling in Renal Clear Cell Carcinoma Progression: Mechanisms and Therapeutic Relevance”
by Sonia Mazumder, Paul J. Higgins and Rohan Samarakoon
Cancers 2023, 15(4), 1316; https://doi.org/10.3390/cancers15041316
Available online: https://www.mdpi.com/2072-6694/15/4/1316

“Unlocking the Resistance to Anti-HER2 Treatments in Breast Cancer: The Issue of HER2 Spatial Distribution”
by Federica Giugliano, Ambra Carnevale Schianca, Chiara Corti, Mariia Ivanova, Nadia Bianco, Silvia Dellapasqua, Carmen Criscitiello, Nicola Fusco, Giuseppe Curigliano and Elisabetta Munzone
Cancers 2023, 15(5), 1385; https://doi.org/10.3390/cancers15051385
Available online: https://www.mdpi.com/2072-6694/15/5/1385

“Risk Assessment and Pancreatic Cancer: Diagnostic Management and Artificial Intelligence”
by Vincenza Granata, Roberta Fusco, Sergio Venanzio Setola, Roberta Galdiero, Nicola Maggialetti, Lucrezia Silvestro, Mario De Bellis, Elena Di Girolamo, Giulia Grazzini, Giuditta Chiti et al.
Cancers 2023, 15(2), 351; https://doi.org/10.3390/cancers15020351
Available online: https://www.mdpi.com/2072-6694/15/2/351

“TGFβ1-Induced EMT in the MCF10A Mammary Epithelial Cell Line Model Is Executed Independently of SNAIL1 and ZEB1 but Relies on JUNB-Coordinated Transcriptional Regulation”
by Pablo Antón-García, Elham Bavafaye Haghighi, Katja Rose, Georg Vladimirov, Melanie Boerries and Andreas Hecht
Cancers 2023, 15(2), 558; https://doi.org/10.3390/cancers15020558
Available online: https://www.mdpi.com/2072-6694/15/2/558

“Pathology of Combined Hepatocellular Carcinoma-Cholangiocarcinoma: An Update”
by Florian Roßner, Bruno Valentin Sinn and David Horst
Cancers 2023, 15(2), 494; https://doi.org/10.3390/cancers15020494
Available online: https://www.mdpi.com/2072-6694/15/2/494

You are welcome to submit relevant papers to the journal Cancers.

Cancers Editorial Office

We are pleased to invite you to read the most viewed Special Issues in 2023 in Cancers (ISSN: 2072-6694) in the Section “Cancer Biomarkers”. The Special Issues list is as follows:

You are welcome to view all the Special Issues and submit relevant papers to the journal Cancers via cancers@mdpi.com.

Cancers Editorial Office

We are pleased to invite you to read the most viewed papers published in Cancers (ISSN: 2072-6694) in 2023 in the Section “Cancer Biomarkers”. The list of papers is as follows:

“Classification of Chondrosarcoma: From Characteristic to Challenging Imaging Findings”
by Jun-Ho Kim and Seul Ki Lee
Cancers 2023, 15(6), 1703; https://doi.org/10.3390/cancers15061703
Available online: https://www.mdpi.com/2072-6694/15/6/1703

“Effect of Selenium and Lycopene on Radiation Sensitivity in Prostate Cancer Patients Relative to Controls”
by Varinderpal S. Dhillon, Permal Deo and Michael Fenech
Cancers 2023, 15(3), 979; https://doi.org/10.3390/cancers15030979
Available online: https://www.mdpi.com/2072-6694/15/3/979

“Aberrant Glycosylation as Immune Therapeutic Targets for Solid Tumors”
by Yasuyuki Matsumoto and Tongzhong Ju
Cancers 2023, 15(14), 3536; https://doi.org/10.3390/cancers15143536
Available online: https://www.mdpi.com/2072-6694/15/14/3536

“Prediction of Prostate Cancer Biochemical and Clinical Recurrence Is Improved by IHC-Assisted Grading Using Appl1, Sortilin and Syndecan-1”
by Jessica M. Logan, Ashley M. Hopkins, Carmela Martini, Alexandra Sorvina, Prerna Tewari, Sarita Prabhakaran, Chelsea Huzzell, Ian R. D. Johnson, Shane M. Hickey, Ben S.-Y. Ung et al.
Cancers 2023, 15(12), 3215; https://doi.org/10.3390/cancers15123215
Available online: https://www.mdpi.com/2072-6694/15/12/3215

“Follicular Lymphoma in the 5th Edition of the WHO-Classification of Haematolymphoid Neoplasms—Updated Classification and New Biological Data”
by Katrin S. Kurz, Sabrina Kalmbach, Michaela Ott, Annette M. Staiger, German Ott and Heike Horn
Cancers 2023, 15(3), 785; https://doi.org/10.3390/cancers15030785
Available online: https://www.mdpi.com/2072-6694/15/3/785

“Mucins as Potential Biomarkers for Early Detection of Cancer”
by Shailendra K. Gautam, Parvez Khan, Gopalakrishnan Natarajan, Pranita Atri, Abhijit Aithal, Apar K. Ganti, Surinder K. Batra, Mohd W. Nasser and Maneesh Jain
Cancers 2023, 15(6), 1640; https://doi.org/10.3390/cancers15061640
Available online: https://www.mdpi.com/2072-6694/15/6/1640

“LC-MS/MS Based Volatile Organic Compound Biomarkers Analysis for Early Detection of Lung Cancer”
by Shuaibu Nazifi Sani, Wei Zhou, Balarabe B. Ismail, Yongkui Zhang, Zhijun Chen, Binjie Zhang, Changqian Bao, Houde Zhang and Xiaozhi Wang
Cancers 2023, 15(4), 1186; https://doi.org/10.3390/cancers15041186
Available online: https://www.mdpi.com/2072-6694/15/4/1186

“Liquid Biopsies, Novel Approaches and Future Directions”
by Athanasios Armakolas, Maria Kotsari and John Koskinas
Cancers 2023, 15(5), 1579; https://doi.org/10.3390/cancers15051579
Available online: https://www.mdpi.com/2072-6694/15/5/1579

“Exploratory Genome-Wide Association Analysis to Identify Pharmacogenetic Determinants of Response to R-CHOP in Diffuse Large B-Cell Lymphoma”
by Gabriele Perrone, Luigi Rigacci, Sara Urru, Sofya Kovalchuk, Marco Brugia, Alberto Fabbri, Lorenzo Iovino, Benedetta Puccini, Emanuele Cencini, Enrico Orciuolo et al.
Cancers 2023, 15(10), 2753; https://doi.org/10.3390/cancers15102753
Available online: https://www.mdpi.com/2072-6694/15/10/2753

“Blood-Based mRNA Tests as Emerging Diagnostic Tools for Personalised Medicine in Breast Cancer”
by Helena Čelešnik and Uroš Potočnik
Cancers 2023, 15(4), 1087; https://doi.org/10.3390/cancers15041087
Available online: https://www.mdpi.com/2072-6694/15/4/1087

You are welcome to submit relevant papers to the journal Cancers. If you have any questions, you can contact the Editorial Office via cancers@mdpi.com.

Cancers Editorial Office

We are pleased to invite you to read the most viewed papers in 2023 in Cancers (ISSN: 2072-6694) on the topic of cancer immunology and immunotherapy. The paper list is as follows:

“Immunotherapy in Melanoma: Recent Advances and Future Directions”
by Andrew Knight, Lilit Karapetyan and John M. Kirkwood
Cancers 2023, 15(4), 1106; https://doi.org/10.3390/cancers15041106
Available online: https://www.mdpi.com/2072-6694/15/4/1106

“Immunotherapy for Triple-Negative Breast Cancer: Combination Strategies to Improve Outcome”
by Liying Li, Fan Zhang, Zhenyu Liu and Zhimin Fan
Cancers 2023, 15(1), 321; https://doi.org/10.3390/cancers15010321
Available online: https://www.mdpi.com/2072-6694/15/1/321

“CAR-T: What Is Next?”
by Yi-Ju Chen, Bams Abila and Yasser Mostafa Kamel
Cancers 2023, 15(3), 663; https://doi.org/10.3390/cancers15030663
Available online: https://www.mdpi.com/2072-6694/15/3/663

“mRNA-Lipid Nanoparticle (LNP) Delivery of Humanized EpCAM-CD3 Bispecific Antibody Significantly Blocks Colorectal Cancer Tumor Growth”
by Vita Golubovskaya, John Sienkiewicz, Jinying Sun, Yanwei Huang, Liang Hu, Hua Zhou, Hizkia Harto, Shirley Xu, Robert Berahovich, Walter Bodmer et al.
Cancers 2023, 15(10), 2860; https://doi.org/10.3390/cancers15102860
Available online: https://www.mdpi.com/2072-6694/15/10/2860

“Emerging Targeted Therapies for HER2-Positive Breast Cancer”
by María Florencia Mercogliano, Sofía Bruni, Florencia Luciana Mauro and Roxana Schillaci
Cancers 2023, 15(7), 1987; https://doi.org/10.3390/cancers15071987
Available online: https://www.mdpi.com/2072-6694/15/7/1987

“Beyond CTLA-4 and PD-1 Inhibition: Novel Immune Checkpoint Molecules for Melanoma Treatment”
by Dimitrios C. Ziogas, Charalampos Theocharopoulos, Panagiotis-Petros Lialios, Dimitra Foteinou, Ioannis-Alexios Koumprentziotis, Georgios Xynos and Helen Gogas
Cancers 2023, 15(10), 2718; https://doi.org/10.3390/cancers15102718
Available online: https://www.mdpi.com/2072-6694/15/10/2718

“Ready for Prime Time? Dendritic Cells in High-Grade Gliomas”
by Claire A. Conarroe and Timothy N. J. Bullock
Cancers 2023, 15(11), 2902; https://doi.org/10.3390/cancers15112902
Available online: https://www.mdpi.com/2072-6694/15/11/2902

“Predictive Biomarkers for Checkpoint Inhibitor Immune-Related Adverse Events”
by Iñigo Les, Mireia Martínez, Inés Pérez-Francisco, María Cabero, Lucía Teijeira, Virginia Arrazubi, Nuria Torrego, Ana Campillo-Calatayud, Iñaki Elejalde, Grazyna Kochan et al.
Cancers 2023, 15(5), 1629; https://doi.org/10.3390/cancers15051629
Available online: https://www.mdpi.com/2072-6694/15/5/1629

“Immunotherapy for Peritoneal Carcinomatosis: Challenges and Prospective Outcomes”
by Mefotse Saha Cyrelle Ornella, Narayanasamy Badrinath, Kyeong-Ae Kim, Jung Hee Kim, Euna Cho, Tae-Ho Hwang and Jae-Joon Kim
Cancers 2023, 15(8), 2383; https://doi.org/10.3390/cancers15082383
Available online: https://www.mdpi.com/2072-6694/15/8/2383

“Lenalidomide in Multiple Myeloma: Review of Resistance Mechanisms, Current Treatment Strategies and Future Perspectives”
by Piotr Kulig, Sławomir Milczarek, Estera Bakinowska, Laura Szalewska, Bartłomiej Baumert and Bogusław Machaliński
Cancers 2023, 15(3), 963; https://doi.org/10.3390/cancers15030963
Available online: https://www.mdpi.com/2072-6694/15/3/963

You are welcome to submit relevant papers to the journal Cancers.

Cancers Editorial Office

We are pleased to invite you to read the most viewed papers in 2023 in Cancers (ISSN: 2072-6694) on the topic of methods and technologies development. The paper list is as follows:

“Multiphysics Modeling of Low-Intensity Pulsed Ultrasound Induced Chemotherapeutic Drug Release from the Surface of Gold Nanoparticles”
by Tyler K. Hornsby, Farshad Moradi Kashkooli, Anshuman Jakhmola, Michael C. Kolios and Jahangir (Jahan) Tavakkoli
Cancers 2023, 15(2), 523; https://doi.org/10.3390/cancers15020523
Available online: https://www.mdpi.com/2072-6694/15/2/523

“Hybrid Quantum Neural Network for Drug Response Prediction”
by Asel Sagingalieva, Mohammad Kordzanganeh, Nurbolat Kenbayev, Daria Kosichkina, Tatiana Tomashuk and Alexey Melnikov
Cancers 2023, 15(10), 2705; https://doi.org/10.3390/cancers15102705
Available online: https://www.mdpi.com/2072-6694/15/10/2705

“New Frontiers in Colorectal Cancer Treatment Combining Nanotechnology with Photo- and Radiotherapy”
by Sara C. Freitas, Daniel Sanderson, Sofia Caspani, Ricardo Magalhães, Belén Cortés-Llanos, Andreia Granja, Salette Reis, João Horta Belo, José Azevedo, Maria Victoria Gómez-Gaviro et al.
Cancers 2023, 15(2), 383; https://doi.org/10.3390/cancers15020383
Available online: https://www.mdpi.com/2072-6694/15/2/383

“Detection Efficacy of 68Ga-PSMA-11 PET/CT in Biochemical Recurrence of Prostate Cancer with Very Low PSA Levels: A 7-Year, Two-Center “Real-World” Experience”
by Caroline Burgard, Manuela A. Hoffmann, Madita Frei, Hans-Georg Buchholz, Fadi Khreish, Robert J. Marlowe, Mathias Schreckenberger, Samer Ezziddin and Florian Rosar
Cancers 2023, 15(5), 1376; https://doi.org/10.3390/cancers15051376
Available online: https://www.mdpi.com/2072-6694/15/5/1376

“Thin-Slice Prostate MRI Enabled by Deep Learning Image Reconstruction”
by Sebastian Gassenmaier, Verena Warm, Dominik Nickel, Elisabeth Weiland, Judith Herrmann, Haidara Almansour, Daniel Wessling and Saif Afat
Cancers 2023, 15(3), 578; https://doi.org/10.3390/cancers15030578
Available online: https://www.mdpi.com/2072-6694/15/3/578

“Micro-Ultrasound: Current Role in Prostate Cancer Diagnosis and Future Possibilities”
by Adriano Basso Dias and Sangeet Ghai
Cancers 2023, 15(4), 1280; https://doi.org/10.3390/cancers15041280
Available online: https://www.mdpi.com/2072-6694/15/4/1280

“CBCT-to-CT Translation Using Registration-Based Generative Adversarial Networks in Patients with Head and Neck Cancer”
by Chitchaya Suwanraksa, Jidapa Bridhikitti, Thiansin Liamsuwan and Sitthichok Chaichulee
Cancers 2023, 15(7), 2017; https://doi.org/10.3390/cancers15072017
Available online: https://www.mdpi.com/2072-6694/15/7/2017

“Henry Gas Solubility Optimization Algorithm based Feature Extraction in Dermoscopic Images Analysis of Skin Cancer”
by Marwa Obayya, Adeeb Alhebri, Mashael Maashi, Ahmed S. Salama, Anwer Mustafa Hilal, Mohamed Ibrahim Alsaid, Azza Elneil Osman and Amani A. Alneil
Cancers 2023, 15(7), 2146; https://doi.org/10.3390/cancers15072146
Available online: https://www.mdpi.com/2072-6694/15/7/2146

“Relative Risk of Bladder and Kidney Cancer in Lynch Syndrome: Systematic Review and Meta-Analysis”
by Anthony-Joe Nassour, Anika Jain, Nicholas Hui, George Siopis, James Symons and Henry Woo
Cancers 2023, 15(2), 506; https://doi.org/10.3390/cancers15020506
Available online: https://www.mdpi.com/2072-6694/15/2/506

“An Overview of Ovarian Cancer: The Role of Cancer Stem Cells in Chemoresistance and a Precision Medicine Approach Targeting the Wnt Pathway with the Antagonist sFRP4”
by Lavanya Varier, S. Mohana Sundaram, Naisarg Gamit and Sudha Warrier
Cancers 2023, 15(4), 1275; https://doi.org/10.3390/cancers15041275
Available online: https://www.mdpi.com/2072-6694/15/4/1275

You are welcome to submit relevant papers to the journal Cancers.

Cancers Editorial Office

We are pleased to invite you to read the most viewed Special Issues in 2023 in Cancers (ISSN: 2072-6694) in the Section “Methods and Technologies Development”. The Special Issues list is as follows:

You are welcome to view all the Special Issues and submit relevant papers to the journal Cancers. You can contact the Editorial Office (cancers@mdpi.com) for any questions you may have.

Cancers Editorial Office

MDPI has been a strong proponent of the open access publishing model right from the beginning. As one of the pioneering fully open access publishers, we firmly believe that unrestricted access to research findings forms the foundation for better transparency, efficiency, and quality control across all scientific disciplines.

In December 2022, we reached a significant milestone by surpassing one million articles published. That is one million articles freely available to all, to circulate and build upon!

Offering free and immediate access to scientific papers empowers scientists to examine, validate, replicate, and expand upon existing results. This not only helps prevent redundancy and optimizes how resources are used but also paves the way for innovative new approaches.

The International Open Access Week takes place from 23 to 29 October 2023, providing a unique opportunity to connect the global movement towards open sharing and open science with the progress of policy transformations at the local level.

Our goal, during Open Access Week as well as throughout the year, is to offer resources for educating people about the benefits of open access publishing. The MDPI Blog offers a wealth of information around open access and open science.

Promoting the values of accessibility, transparency, and collaboration

Open access publishing embodies the fundamental values of democratizing knowledge and fostering global accessibility. It aims to break down barriers that have traditionally limited access to scholarly work, ensuring that knowledge is available to all, regardless of their financial or institutional affiliations. 

Discounts are part of our commitment to ensuring there are diverse pathways to Open Access publishing for researchers worldwide. MDPI supports scientific communities in several different ways. 

One of the key strengths of open access publishing lies in its ability to facilitate interdisciplinary research. By removing paywalls and promoting the sharing of knowledge across disciplines, OA encourages collaboration and innovation. Researchers from diverse fields can access and build upon each other's work, fostering a holistic approach to addressing complex global challenges. 

Funders' policies are getting aligned with open science

Governments, institutions, and funding agencies have recognized the transformative potential of open access and have implemented policies to promote it. These policies often mandate that publicly funded research should be made openly accessible. Such initiatives have accelerated the growth of open access repositories and journals, reinforcing the commitment to open access principles. Check our spotlights on OA policies in the US, EU and China. 

Open access publishing is continually evolving, with innovative and community-driven models and technologies shaping its future. Initiatives like "Plan S" and "cOAlition S" promote the adoption of OA publishing from the national funders’ perspective by requiring grantees to publish their research openly. A new policy announced by the US administration last year requires that, as of January 2026, all US federally funded research be made freely and immediately available after publication. 

Additionally, preprint servers such as MDPI's Preprints.org, which allow researchers to share their findings before formal peer review, have gained popularity, enhancing the speed at which new knowledge is disseminated. The rise of blockchain technology is also being explored to ensure transparency and authenticity in scholarly publishing. 

For more than twenty years, open access scholarly publishing has been revolutionizing academia by promoting the values of accessibility, transparency, and collaboration. Its support for interdisciplinary research, evolving policies, and innovative practices all contribute to its growing influence in the global research community. As open access continues to expand, it holds the potential to democratize knowledge, advance science, and drive positive societal change. 

MDPI is proud to be a leader in the transition to open access.

We are pleased to invite you to read the most viewed papers in 2023 in Cancers (ISSN: 2072-6694) on the topic of cancer causes, screening and diagnosis. The paper list is as follows:

“Circulating Chromosome Conformation Signatures Significantly Enhance PSA Positive Predicting Value and Overall Accuracy for Prostate Cancer Detection”
by Dmitri Pchejetski, Ewan Hunter, Mehrnoush Dezfouli, Matthew Salter, Ryan Powell, Jayne Green, Tarun Naithani, Christina Koutsothanasi, Heba Alshaker, Jiten Jaipuria et al.
Cancers 2023, 15(3), 821; https://doi.org/10.3390/cancers15030821
Available online: https://www.mdpi.com/2072-6694/15/3/821

“DSCC_Net: Multi-Classification Deep Learning Models for Diagnosing of Skin Cancer Using Dermoscopic Images”
by Maryam Tahir, Ahmad Naeem, Hassaan Malik, Jawad Tanveer, Rizwan Ali Naqvi and Seung-Won Lee
Cancers 2023, 15(7), 2179; https://doi.org/10.3390/cancers15072179
Available online: https://www.mdpi.com/2072-6694/15/7/2179

“Is Pediatric Melanoma Really That Different from Adult Melanoma? A Multicenter Epidemiological, Clinical and Dermoscopic Study”
by Vincenzo De Giorgi, Elisabetta Magnaterra, Biancamaria Zuccaro, Serena Magi, Manfredi Magliulo, Matelda Medri, Laura Mazzoni, Federico Venturi, Flavia Silvestri, Gian Marco Tomassini et al.
Cancers 2023, 15(6), 1835; https://doi.org/10.3390/cancers15061835
Available online: https://www.mdpi.com/2072-6694/15/6/1835

“DNA Damage Response Alterations in Ovarian Cancer: From Molecular Mechanisms to Therapeutic Opportunities”
by María Ovejero-Sánchez, Rogelio González-Sarmiento and Ana Belén Herrero
Cancers 2023, 15(2), 448; https://doi.org/10.3390/cancers15020448
Available online: https://www.mdpi.com/2072-6694/15/2/448

“Targeting the Molecular and Immunologic Features of Leiomyosarcoma”
by Brandon M. Cope, Raymond S. Traweek, Rossana Lazcano, Emily Z. Keung, Alexander J. Lazar, Christina L. Roland and Elise F. Nassif
Cancers 2023, 15(7), 2099; https://doi.org/10.3390/cancers15072099
Available online: https://www.mdpi.com/2072-6694/15/7/2099

“Current and Emerging Techniques for Diagnosis and MRD Detection in AML: A Comprehensive Narrative Review”
by Alexandra Teixeira, Luís Carreira, Sara Abalde-Cela, Belém Sampaio-Marques, Anabela C. Areias, Paula Ludovico and Lorena Diéguez
Cancers 2023, 15(5), 1362; https://doi.org/10.3390/cancers15051362
Available online: https://www.mdpi.com/2072-6694/15/5/1362

“Retroperitoneal Lymph Node Dissection in Colorectal Cancer with Lymph Node Metastasis: A Systematic Review”
by Michael G. Fadel, Mosab Ahmed, Gianluca Pellino, Shahnawaz Rasheed, Paris Tekkis, David Nicol, Christos Kontovounisios and Erik Mayer
Cancers 2023, 15(2), 455; https://doi.org/10.3390/cancers15020455
Available online: https://www.mdpi.com/2072-6694/15/2/455

“Outcomes of Robot-Assisted Surgery in Rectal Cancer Compared with Open and Laparoscopic Surgery”
by Elias Khajeh, Ehsan Aminizadeh, Arash Dooghaie Moghadam, Rajan Nikbakhsh, Gil Goncalves, Carlos Carvalho, Amjad Parvaiz, Yakup Kulu and Arianeb Mehrabi
Cancers 2023, 15(3), 839; https://doi.org/10.3390/cancers15030839
Available online: https://www.mdpi.com/2072-6694/15/3/839

“Breast Cancer Risk and Breast-Cancer-Specific Mortality following Risk-Reducing Salpingo-Oophorectomy in BRCA Carriers: A Systematic Review and Meta-Analysis”
by Faiza Gaba, Oleg Blyuss, Alex Tan, Daniel Munblit, Samuel Oxley, Khalid Khan, Rosa Legood and Ranjit Manchanda
Cancers 2023, 15(5), 1625; https://doi.org/10.3390/cancers15051625
Available online: https://www.mdpi.com/2072-6694/15/5/1625

“Oral Human Papillomavirus Benign Lesions and HPV-Related Cancer in Healthy Children: A Systematic Review”
by Federica Di Spirito, Giuseppe Pantaleo, Maria Pia Di Palo, Alessandra Amato, Annunziata Raimondo and Massimo Amato
Cancers 2023, 15(4), 1096; https://doi.org/10.3390/cancers15041096
Available online: https://www.mdpi.com/2072-6694/15/4/1096

You are welcome to submit relevant papers to the journal Cancers.

Cancers Editorial Office

We are pleased to invite you to read the most viewed Special Issues in 2023 in Cancers (ISSN: 2072-6694) in the Section “Cancer Survivorship and Quality of Life”. The Special Issues list is as follows:

You are welcome to view all the Special Issues and submit relevant papers to the journal Cancers via cancers@mdpi.com.

Cancers Editorial Office

We are pleased to invite you to read the most viewed papers in 2023 in Cancers (ISSN: 2072-6694) in the Section “Systematic Review or Meta-Analysis in Cancer Research”. The paper list is as follows:

“The Emerging Role of PET/CT with PSMA-Targeting Radiopharmaceuticals in Clear Cell Renal Cancer: An Updated Systematic Review”
by Alessio Rizzo, Manuela Racca, Sara Dall’Armellina, Pasquale Rescigno, Giuseppe Luigi Banna, Domenico Albano, Francesco Dondi, Francesco Bertagna, Salvatore Annunziata and Giorgio Treglia
Cancers 2023, 15(2), 355; https://doi.org/10.3390/cancers15020355
Available online: https://www.mdpi.com/2072-6694/15/2/355

“A Systematic Review of High-Dose Methotrexate for Adults with Primary Central Nervous System Lymphoma"
by Gabriela Villanueva, Martin Guscott, Paula Schaiquevich, Claudia Sampor, Ryan Combs, Nicolás Tentoni, Miriam Hwang, Jennifer Lowe and Scott Howard
Cancers 2023, 15(5), 1459; https://doi.org/10.3390/cancers15051459
Available online: https://www.mdpi.com/2072-6694/15/5/1459

“Natural Progression of Left Ventricular Function following Anthracyclines without Cardioprotective Therapy: A Systematic Review and Meta-Analysis”
by Ainsley Ryan Yan Bin Lee, Chun En Yau, Chen Ee Low, Jiaqi Li, Sara Moiz Tyebally, Weiqin Lin, Li-Ling Tan, Chia-Te Liao, Wei-Ting Chang, Matilda Xinwei Lee et al.
Cancers 2023, 15(2), 512; https://doi.org/10.3390/cancers15020512
Available online: https://www.mdpi.com/2072-6694/15/2/512

“Effectiveness of Colorectal Cancer (CRC) Screening on All-Cause and CRC-Specific Mortality Reduction: A Systematic Review and Meta-Analysis”
by Senshuang Zheng, Jelle J. A. Schrijvers, Marcel J. W. Greuter, Gürsah Kats-Ugurlu, Wenli Lu and Geertruida H. de Bock
Cancers 2023, 15(7), 1948; https://doi.org/10.3390/cancers15071948
Available online: https://www.mdpi.com/2072-6694/15/7/1948

“The Association between Early-Onset Diagnosis and Clinical Outcomes in Triple-Negative Breast Cancer: A Systematic Review and Meta-Analysis”
by Brandon M. Cope, Raymond S. Traweek, Rossana Lazcano, Emily Z. Keung, Alexander J. Lazar, Christina L. Roland and Elise F. Nassif
Cancers 2023, 15(7), 2099; https://doi.org/10.3390/cancers15072099
Available online: https://www.mdpi.com/2072-6694/15/7/2099

“New Insights in the Era of Clinical Biomarkers as Potential Predictors of Systemic Therapy-Induced Cardiotoxicity in Women with Breast Cancer: A Systematic Review”
by Alexia Alexandraki, Elisavet Papageorgiou, Marina Zacharia, Kalliopi Keramida, Andri Papakonstantinou, Carlo M. Cipolla, Dorothea Tsekoura, Katerina Naka, Ketti Mazzocco, Davide Mauri et al.
Cancers 2023, 15(13), 3290; https://doi.org/10.3390/cancers15133290
Available online: https://www.mdpi.com/2072-6694/15/13/3290

“Candidate Genes and Pathways in Cervical Cancer: A Systematic Review and Integrated Bioinformatic Analysis”
by Marjanu Hikmah Elias, Srijit Das and Nazefah Abdul Hamid
Cancers 2023, 15(3), 853; https://doi.org/10.3390/cancers15030853
Available online: https://www.mdpi.com/2072-6694/15/3/853

“Frequency of Germline and Somatic BRCA1 and BRCA2 Mutations in Prostate Cancer: An Updated Systematic Review and Meta-Analysis”
by Anna Amela Valsecchi, Rossana Dionisio, Olimpia Panepinto, Jessica Paparo, Andrea Palicelli, Francesca Vignani and Massimo Di Maio
Cancers 2023, 15(9), 2435; https://doi.org/10.3390/cancers15092435
Available online: https://www.mdpi.com/2072-6694/15/9/2435

“Occupational Exposures and Risks of Non-Hodgkin Lymphoma: A Meta-Analysis”
by Luiza Flavia Veiga Francisco, Rogério Nunes da Silva, Marco Antônio Oliveira, Martins Fideles dos Santos Neto, Iara Zapparoli Gonçalves, Márcia M. C. Marques and Henrique C. S. Silveira
Cancers 2023, 15(9), 2600; https://doi.org/10.3390/cancers15092600
Available online: https://www.mdpi.com/2072-6694/15/9/2600

“Deep Learning for Lung Cancer Diagnosis, Prognosis and Prediction Using Histological and Cytological Images: A Systematic Review”
by Athena Davri, Effrosyni Birbas, Theofilos Kanavos, Georgios Ntritsos, Nikolaos Giannakeas, Alexandros T. Tzallas and Anna Batistatou
Cancers 2023, 15(15), 3981; https://doi.org/10.3390/cancers15153981
Available online: https://www.mdpi.com/2072-6694/15/15/3981

You are welcome to submit relevant papers to the journal Cancers.

Cancers Editorial Office